...
首页> 外文期刊>American Journal of Physiology >Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout.
【24h】

Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout.

机译:硫化氢作为鳟鱼血管平滑肌张力的内源性调节剂。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hydrogen sulfide (H(2)S) is an endogenous vasodilator in mammals, but its presence and function in other vertebrates is unknown. We generated H(2)S from NaHS and examined the effects on isolated efferent branchial arteries from steelhead (stEBA) or rainbow (rtEBA) trout. H(2)S concentration was measured colorimetrically (CM) and with ion-selective electrodes (ISE) in rainbow trout plasma. NaHS produced a triphasic response consisting of a relaxation (phase 1), constriction (phase 2), and relaxation (phase 3) in both unstimulated vessels and in stEBA precontracted with carbachol (Carb). Phase 1 and phase 3 in stEBA were decreased and phase 2 increased in unstimulated vessels by K(+)(ATP) channel inhibition (glibenclamide), or a cocktail of inhibitors of cyclooxygenase, lipoxygenase, and cytochrome P-450 (indomethacin, esculetin, and clotrimazole). Inhibition of soluble guanylate cyclase with ODQ o NS-2028 inhibited phase 3 in stEBA, although NaHS decreased cGMP production by tEBA. stEBA phase 2 contractions were partially inhibited by the myosin light chain kinase inhibitor, ML-9, but unaffected by L-type calcium channel inhibition (methoxyverapamil), whereas contraction in tEBA was partially inhibited by nifedipine or removal of extracellular calcium. Phase 3 relaxations were more pronounced in stEBA precontracted with Carb and no epinephrine (NE) than those cont acted by KCl or K(2)SO(4). stEBA phase 2 and phase 3 responses were dose dependent (EC(50) = 1.1 +/- 1.2 x 10(-3) M and 6.7 +/- 0.9 x 10(-5) M, respectively; n = 7). NaHS was also vasoactive in steelhead bulbus arteriosus, celiac mesenteric arteries, and anterior cardinal veins. Rainbow trout plasma sulfide concentration was 4.0 +/- 0.3 x 10(-5) M, n = 4 (CM) and 3.8 +/- 0.4 x 10(-5) M, n = 9 (ISE); similar to phase 3 EC(50). Because NaHS has substantial vasoactive effects at physiological plasma concentrations, we propose that its soluble derivative, H(2)S, is a tonically active endogenous vasoregulator in trout.
机译:硫化氢(H(2)S)是哺乳动物中的内源性血管扩张剂,但其在其他脊椎动物中的存在和功能尚不清楚。我们从NaHS生成H(2)S,并检查了对虹鳟(stEBA)或虹鳟(rtEBA)的孤立传出分支动脉的影响。 H(2)S浓度是用比色法(CM)和虹鳟血浆中的离子选择电极(ISE)测量的。 NaHS在未刺激的血管和预先与卡巴胆碱(Carb)签约的stEBA中产生了由松弛(阶段1),收缩(阶段2)和松弛(阶段3)组成的三相响应。通过K(+)(ATP)通道抑制作用(glibenclamide)或一系列环氧合酶,脂氧合酶和细胞色素P-450抑制剂(吲哚美辛,七叶皂苷,和克霉唑)。尽管NaHS降低了tEBA产生的cGMP量,但用ODQ对NS-2028的可溶性鸟苷酸环化酶的抑制作用抑制了stEBA的第3期。 stEBA 2期收缩部分被肌球蛋白轻链激酶抑制剂ML-9抑制,但不受L型钙通道抑制作用(甲氧基维拉帕米)的影响,而tEBA的收缩被硝苯地平或细胞外钙的去除部分抑制。与用氯化钾或K(2)SO(4)竞争的stEBA预先用Carb和没有肾上腺素(NE)的合同,第3阶段的放松更为明显。 stEBA的第2阶段和第3阶段响应是剂量依赖性的(EC(50)= 1.1 +/- 1.2 x 10(-3)M和6.7 +/- 0.9 x 10(-5)M; n = 7)。 NaHS在头状干动脉,腹腔肠系膜动脉和主要前静脉中也具有血管活性。虹鳟血浆硫化物浓度为4.0 +/- 0.3 x 10(-5)M,n = 4(CM)和3.8 +/- 0.4 x 10(-5)M,n = 9(ISE);类似于第3阶段EC(50)。因为NaHS在生理血浆浓度下具有实质性血管活性作用,所以我们提出其可溶性衍生物H(2)S是鳟鱼中的一种具有声调活性的内源性血管调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号